ACE2 and non-small cell lung carcinoma: In non-small cell lung carcinoma, ACE2 overexpression inhibits TGF-β1-induced epithelial to mesenchymal transition (EMT) and Ang II-driven VEGFa signaling that ultimately lessens cancer cell metastasis (Feng et al., 2010; Qian et al., 2013).